76 related articles for article (PubMed ID: 2626948)
1. [Hypothyroidism following combined treatment of pharyngolaryngeal carcinoma].
Magnano M; Pia F; Amasio ME; Gabriele P
Acta Otorhinolaryngol Ital; 1989; 9(5):439-45. PubMed ID: 2626948
[TBL] [Abstract][Full Text] [Related]
2. [The effect of laryngectomy and postoperative radiotheraphy on thyroid gland functions].
Cinar U; Yiğit O; Alkan S; Uslu B; Topuz E; Unsal O; Akgül G; Dadaş B
Kulak Burun Bogaz Ihtis Derg; 2003 Jun; 10(6):226-30. PubMed ID: 13679689
[TBL] [Abstract][Full Text] [Related]
3. Hypothyroidism after radiotherapy for patients with head and neck cancer.
Ozawa H; Saitou H; Mizutari K; Takata Y; Ogawa K
Am J Otolaryngol; 2007; 28(1):46-9. PubMed ID: 17162132
[TBL] [Abstract][Full Text] [Related]
4. [Prophylactic postoperative radiotherapy in the treatment of supraglottic tumors].
Esposito E; Motta S; Cassiano B; Motta G
Acta Otorhinolaryngol Ital; 2000 Dec; 20(6):432-41. PubMed ID: 11398681
[TBL] [Abstract][Full Text] [Related]
5. Thyroid function after radiation and surgery for head and neck cancer.
Shafer RB; Nuttall FQ; Pollak K; Kuisk H
Arch Intern Med; 1975 Jun; 135(6):843-6. PubMed ID: 1130929
[TBL] [Abstract][Full Text] [Related]
6. [Hypothyroidism after combined surgical and radiotherapy treatment of cancer of the ORL area].
Auberson S; Kündig H
Schweiz Med Wochenschr Suppl; 2000; 116():50S-53S. PubMed ID: 10780072
[TBL] [Abstract][Full Text] [Related]
7. Split therapy: planned neck dissection followed by definitive radiotherapy for a T1, T2 pharyngolaryngeal primary cancer with operable N2, N3 nodal metastases--a prospective study.
D'cruz AK; Pantvaidya GH; Agarwal JP; Chaukar DA; Pathak KA; Deshpande MS; Pai PS; Chaturvedi P; Dinshaw KA
J Surg Oncol; 2006 Jan; 93(1):56-61. PubMed ID: 16353188
[TBL] [Abstract][Full Text] [Related]
8. Transoral laser surgery for pharyngeal and pharyngolaryngeal carcinomas.
Kutter J; Lang F; Monnier P; Pasche P
Arch Otolaryngol Head Neck Surg; 2007 Feb; 133(2):139-44. PubMed ID: 17309982
[TBL] [Abstract][Full Text] [Related]
9. Hypothyroidism following combined therapy in carcinoma of the laryngopharynx.
Murken RE; Duvall AJ
Laryngoscope; 1972 Jul; 82(7):1306-14. PubMed ID: 5078646
[No Abstract] [Full Text] [Related]
10. [Induction chemotherapy and laryngeal preservation in pharyngolaryngeal carcinomas. Study of a 124 serie's patients and patient's follow up with laryngeal preservation].
Bessède JP; Vinh D; Genet D; Khalifa N; Aubry K; Rhein B; Orsel S; Tubiana-Mathieu N; Clavère P
Rev Laryngol Otol Rhinol (Bord); 2004; 125(2):81-8. PubMed ID: 15462166
[TBL] [Abstract][Full Text] [Related]
11. Hypothyroidism in head and neck cancer patients: experimental and clinical observations.
Cannon CR
Laryngoscope; 1994 Nov; 104(11 Pt 2 Suppl 66):1-21. PubMed ID: 7968176
[TBL] [Abstract][Full Text] [Related]
12. Hypothyroidism after therapy for larynx and pharynx carcinoma.
Smolarz K; Malke G; Voth E; Scheidhauer K; Eckel HE; Jungehülsing M; Schicha H
Thyroid; 2000 May; 10(5):425-9. PubMed ID: 10884190
[TBL] [Abstract][Full Text] [Related]
13. [Hypothyroidism in patients treated for laryngeal cancer: preliminary results].
Romero A; Esteban F; Delgado M; Solanellas J; Soldado L; Fernández I; Hidalgo J; Rodríguez Adrados F
Acta Otorrinolaringol Esp; 1999 Apr; 50(3):205-10. PubMed ID: 10362864
[TBL] [Abstract][Full Text] [Related]
14. [Hypothyroidism incidence after multimodal treatment for laryngeal cancer].
Ortega-Gutiérrez C; Luna-Ortiz K; Villavicencio-Valencia V; Herrera Gómez A; Téllez-Palacios D; Contreras-Buendía M
Cir Cir; 2012; 80(5):448-50. PubMed ID: 23351449
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of patients with malignant laryngeal and pharyngeal neoplasms].
Pogosov VS; Sarkisova FR; Smetanin IG
Vestn Otorinolaringol; 1995; (4):5-8. PubMed ID: 7676564
[TBL] [Abstract][Full Text] [Related]
16. Complications of combined radiation therapy and surgery for carcinoma of the larynx and inferior hypopharynx.
Thawley SE
Laryngoscope; 1981 May; 91(5):677-700. PubMed ID: 7231019
[TBL] [Abstract][Full Text] [Related]
17. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
[TBL] [Abstract][Full Text] [Related]
18. Thyroid dysfunction in patients treated with radiotherapy for neck.
Koc M; Capoglu I
Am J Clin Oncol; 2009 Apr; 32(2):150-3. PubMed ID: 19307948
[TBL] [Abstract][Full Text] [Related]
19. [Contribution of the combination of radiation and surgery in the treatment of invasive pharyngo-laryngeal carcinoma].
Faucher A; Renaud-Salis JL; Mauruc B; Richaud P; Touchard J
Ann Otolaryngol Chir Cervicofac; 1988; 105(7):539-42. PubMed ID: 3218823
[TBL] [Abstract][Full Text] [Related]
20. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
